Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

An AI-powered heart disease test from Chicago firm is expanding to its first international market. Learn more here.

As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...

Patients will be able to undergo medical tests at any private hospital or diagnostic centre at rates currently applicable in government hospitals ...

The company said the Centre of Genomics will be supported by two CAP-accredited genomics laboratories located in Mumbai and ...

Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...

The new centre will be backed by two CAP-accredited genomics laboratories in Mumbai and Delhi NCR, and will support ...

Among patients with asthma-like symptoms in primary care, testing using home spirometry may be useful for the diagnosis of ...

Many health insurance plans are required by the Affordable Care Act (ACA) to cover certain STD screenings without ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...